Transcriptional control in keratinocytes and fibroblasts using synthetic ligands

Journal of Clinical Investigation

Volumn 99, Issue 11, 1997, Pages 2610-2615

  Freiberg, Rachel A ^a,b   Ho, Steffan N ^a,b   Khavari, Paul A ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Fibroblasts; Gene regulation; Keratinocytes; Skin; Transcriptional control

Indexed keywords

FK 506 BINDING PROTEIN; HYBRID PROTEIN; LIGAND; TACROLIMUS;

ARTICLE; DNA BINDING; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; OLIGOMERIZATION; PRIORITY JOURNAL; SKIN; TRANSCRIPTION REGULATION;

EID: 0030911791     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119449     Document Type: Article

References (27)

1. Oltvai Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609-619.
2. Fenjves, E.S., J. Smith, S. Zaradic, and L.B. Taichman. 1994. Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy. Hum. Gene Ther. 5(10):1241-1248.
3. Ferez, J.R., S. Shull, G.J. Gendimenico, R.J. Capetola, J.A. Mezick, and K.R. Cutroneo. 1992. Glucocorticoid and retinoid regulation of alpha-2 type I procollagen promoter activity. J. Cell Biochem. 50:26-34.
4. Qu, Z., S. Fujimoto, and T. Taniguchi. 1994. Enhancement of interferon-gamma-induced major histocompatibility complex class II gene expression by expressing an antisense RNA of poly(ADP-ribose) synthetase. J. Biol. Chem. 269:5543-5547.
5. Gossen, M., S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science (Wash. DC). 268:1766-1769.
6. Heldin, C.H. 1995. Dimerization of cell surface receptors in signal transduction. Cell. 80:213-223.
7. Schule, R., and R.M. Evans. 1991. Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet. 7:377-381.
8. Davis, M.M., and P.J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature (Lond.). 334:395-402. Erratum appears in Nature (Lond.). 1988; 335:744.
9. Kerppola, T.K., and T. Curran. 1991. Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity. Cell. 66:317-326.
10. Kolanus, W., C. Romeo, and B. Seed. 1993. T cell activation by clustered tyrosine kinases. Cell. 74:171-183.
11. Spencer, D.M., T.J. Wandless, S.L. Schreiber, and G.R. Crabtree. 1993. Controlling signal transduction with synthetic ligands [see comments]. Science (Wash. DC). 262:1019-1024.
12. Jiang, H., S. Yamamoto, and R. Kato. 1995. Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant. J. Invest. Dermatol. 104:523-525.
13. Lauerma, A.I., B.D. Stein, B. Homey, C.H. Lee, E. Bloom, and H.I. Maibach. 1994. Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. Arch. Dermatol. Res. 286:337-340.
14. Rheinwald, J.G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 6:331-343.
15. Balcar, V.J., J. Shen, S. Bao, and N.J. King. 1994. Na(+)-dependent high affinity uptake of L-glutamate in primary cultures of human fibroblasts isolated from three different types of tissue. FEBS Lett. 339:50-54.
16. Jiang, C.K., D. Connolly, and M. Blumenberg. 1991. Comparison of methods for transfection of human epidermal keratinocytes. J. Invest. Dermatol. 97:969-973.
17. Ho, S.N., S.R. Biggar, D.M. Spencer. S.L. Schreiber, and G.R. Crabtree. 1996. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature (Lond.). 382:822-826.
18. Chang, H.L., M.H. Zaroukian, and W.J. Esselman. 1989. T200 alternate exon use in murine lymphoid cells determined by reverse transcription-polymerase chain reaction. J. Immunol. 143:315-321.
19. Jiang, C.K., H.S. Epstein, M. Tomic, I.M. Freedberg, and M. Blumenberg. 1991. Functional comparison of the upstream regulatory DNA sequences of four human epidermal keratin genes. J. Invest. Dermatol. 96:162-167.
20. Unemori, E.N., C. Mauch, W. Hoeffler, Y. Kim, E.P. Amento, and E.A. Bauer. 1994. Constitutive activation of the collagenase promoter in recessive dystrophic epidermolysis bullosa fibroblasts: role of endogenously activated AP-1. Exp. Cell Res. 211:212-218.
21. Starr, D.B., W. Matsui, J.R. Thomas, and K.R. Yamamoto. 1996. Intracellular receptors use a common mechanism to interpret signaling information at response elements. Genes Dev. 10:1271-1283.
22. Breitkreutz, D., H.J. Stark, P. Plein, M. Baur, and N.E. Fusenig. 1993. Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular Ca2+. Differentiation. 54:201-217.
23. Anson, D.S., J. Bielicki, and J.J. Hopwood. 1992. Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene. Hum. Gene Ther. 3:371-379.
24. Fenjves, E.S., D.A. Gordon, L.K. Pershing, D.L. Williams, and L.B. Taichman. 1989. Synthesis distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy. Proc. Natl. Acad. Sci. U.S.A. 86:8803-8807.
25. Gerrard, A.J., D.L. Hudson, G.G. Brownlee, and P.M. Watt. 1993. Towards gene therapy for haemophilia B using primary human keratinocytes. Nat. Genet. 3:180-183.
26. Jensen, U.B., T.G. Jensen, P.K. Jensen, J. Rygaard, B.S. Hansen, J. Fogh, S. Kolvraa, and L. Bolund. 1994. Gene transfer into cultured human epidermis and its transplantation onto immunodeficient mice: an experimental model for somatic gene therapy. J. Invest. Dermatol. 103:391-394.
27. Krueger, G.G., J.R. Morgan, C.M. Jorgensen, L. Schmidt, H.L. Li, M.K. Kwan, S.T. Boyce, H.S. Wiley, J. Kaplan, and M.J. Petersen. 1994. Genetically modified skin to treat disease: potential and limitations. J. Invest. Dermatol. 103:76S-84S.